To provide a clearer understanding of the observed effects of MSN-LFA-Dox and the role of folic acid for active targeting toward the tumor cells, future studies should aim to control for zeta potential in both functionalized and non-functionalized MSNs, and to incorporate cell lines known to lack FOLR1 expression as controls. This evidence concerns the gene FOLR1 and neoplasm.